Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Invested Capital (2022 - 2025)

Autolus Therapeutics (AUTL) has disclosed Return on Invested Capital for 4 consecutive years, with 0.77% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Invested Capital fell 42.0% year-over-year to 0.77%, compared with a TTM value of 0.77% through Jun 2025, down 42.0%, and an annual FY2024 reading of 0.9%, down 3.0% over the prior year.
  • Return on Invested Capital was 0.77% for Q2 2025 at Autolus Therapeutics, down from 0.68% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.35% in Q2 2024 and bottomed at 1.23% in Q4 2023.
  • Average Return on Invested Capital over 4 years is 0.6%, with a median of 0.53% recorded in 2024.
  • The sharpest move saw Return on Invested Capital tumbled -75bps in 2023, then surged 69bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.48% in 2022, then tumbled by -156bps to 1.23% in 2023, then soared by 56bps to 0.54% in 2024, then plummeted by -43bps to 0.77% in 2025.
  • Business Quant data shows Return on Invested Capital for AUTL at 0.77% in Q2 2025, 0.68% in Q1 2025, and 0.54% in Q4 2024.